TP53 DNA binding domain mutations predict progression-free survival of bevacizumab therapy in metastatic colorectal cancer

Hung Chih Hsu, Jeng Fu You, Shu Jen Chen, Hua Chien Chen, Chien Yuh Yeh, Wen Sy Tsai, Hsin Yuan Hung, Tsai Sheng Yang, Nina Lapke*, Kien Thiam Tan

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'TP53 DNA binding domain mutations predict progression-free survival of bevacizumab therapy in metastatic colorectal cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology